Novo Nordisk NVO has outperformed the market over the past 10 years by 4.53% on an annualized basis producing an average annual return of 14.6%. Currently, Novo Nordisk has a market capitalization of $316.53 billion.
Buying $100 In NVO: If an investor had bought $100 of NVO stock 10 years ago, it would be worth $393.58 today based on a price of $140.74 for NVO at the time of writing.
Novo Nordisk’s Performance Over Last 10 Years
Finally — what’s the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.